View Author
study psoriasis patient disease exposure cohort melanoma control nsaid examination level factor association dermatol treatment population effect efalizumab dermatology strobe result epidemiology statin cancer reference 1.00 analyses group follow-up severity nijsten analysis table number trial model erasmus mc period participant center incidence outcome research variable distribution information score quality case –control study –control case series therapy method risk factors health journal report condition www.archdermatol.com cohort study psoriasis severity measure design statin use people assessment evidence erasmu rotterdam cohort studies safety pga levels 11 items skin disease difference duration prevalence series risk factor rotterdam user
